Effect of time and place of subcutaneous injection of Enoxaparin on the severity of pain and size of bruising

Comparing the effectiveness of the duration and site of subcutaneous injection of enoxaparin on pain intensity and bruising size in patients hospitalized to the Department of Cardiac Care

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150106020581N2

Enrollment

Registered

2019-03-13

Start date

2019-02-20

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and bruise.

Interventions

Intervention 1: Intervention group: Enoxaparin medicine according to physician's orders (40 or 60 mg) will be injected subcutaneously into the abdomen and arm area with 30 seconds method.In this metho

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age range 20 to 75 years Physiological stable condition Being able to understand and express pain Platelet count in normal range Body mass index (BMI) ranging from 18.5 to 30

Exclusion criteria

Exclusion criteria: Analgesic use, four hours before the intervention Swelling, ulcer, scratches and erythema in the injection site Muscular and dermal disease and Known coagulopathy

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Immediately after subcutaneous injection of Enoxaparin. Method of measurement: Visual-Analogue Scale of pain(VAS).;Bruising size. Timepoint: 24 and 48 hours after each subcutaneous injection of Enoxaparin. Method of measurement: Transparent millimeter ruler.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Abbasi Mendi

Zahedan University of Medical Sciences

abbasi.ali@gmu.ac.ir+98 54 3344 2482

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026